← FDA Drug Approvals (Drugs@FDA)

ERDAFITINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2026-02-02

Drug application

FDA Application #

ANDA218578

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERDAFITINIB

Generic name

Erdafitinib

Active ingredients

ERDAFITINIB

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

NATCO PHARMA LTD

First approval

2026-02-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown